Pharma and Healthcare: Q1FY26: Steady Revenues, Margins Under Pressure
he India Pharma and Healthcare sector is expected to see steady revenue growth. However, EBITDA margins are expected to show a decline for Q1FY26E
284 Views
Axis Top Picks for the month of July 2025
Our Top Picks Basket has delivered an impressive return of 336% since its inception (May’20), which stands well above the 175% return delivered by...
414 Views
Top Conviction Ideas - “Pharmaceutical & Hospitals” - Q4FY25 Pharma Review
The pharmaceutical universe under our coverage reported Q4FY25 growth of 12.3% YoY and 2.3% QoQ, driven by strong growth in the India business...
232 Views
Axis Top Picks for the Month of June 2025
The Axis Top Picks Basket delivered a return of 15.3% in the last three months against the 11.9% return posted by the Nifty 50, outperforming the...
375 Views
HSIE Results Daily: Max Healthcare Institute, Mankind Pharma, J Kumar Infraprojects
Max Healthcare Institute: EBITDA^ grew 28% YoY, with 29% YoY sales growth (hospital sales up 29%, acquired/new unit sales at INR 3.9 bn, and Max...
218 Views